Enhancing the lipid peroxidation clearance capability of effector CD8+ T cells or adoptively transferring lipid peroxidation-resistant CD8+ T cells may be promising strategies to enhance the effectiveness of cancer immunotherapy. Here, CD8A is linked to cancer.